Skip to main content
Erschienen in: Infection 6/2017

20.08.2017 | Case Report

Peritonitis in a neonate due to Cyberlindnera fabianii, an ascomycetic yeast

verfasst von: H. Hof, V. Amann, C. Tauber, A. Paulun

Erschienen in: Infection | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

The ascomycetous yeast Cyberlindera fabianii is not only present in the environment, but is also occasionally pathogenic. Especially, neonates seem to be prone to infection. Here, we describe a case of peritoneal infection of a neonate after congenital heart surgery. The correct identification of this peculiar species is made by MALDI-TOF and especially by molecular biology methods, whereas the standard biochemical identification methods fail.The neonate with a hypoplastic left heart syndrome had a Norwood palliation followed by transient ECMO therapy for 3 days. The patient developed a renal insufficiency, so that peritoneal dialysis was initiated. After a few days, a peritoneal infection due to C. fabianii emerged. The proper source of this rare and particular yeast remains obscure. In spite of a reasonable antimycotic therapy, the patient developed a capillary leak syndrome and died finally in septic shock with multiorgan failure. One reason is probably that the yeast population, which was highly susceptible to all common antimycotic drugs at the beginning of therapy with fluconazole (and for a short period with caspofungin and liposomal amphotericin B), became rapidly resistant.
Literatur
1.
Zurück zum Zitat Hof H, Eigner U, Maier T, Staib P. Differentiation of Candida dubliniensis from Candida albicans by means of MALDI-TOF. Clin Lab. 2012;58:927–31.PubMed Hof H, Eigner U, Maier T, Staib P. Differentiation of Candida dubliniensis from Candida albicans by means of MALDI-TOF. Clin Lab. 2012;58:927–31.PubMed
2.
Zurück zum Zitat Gorton RL, Seaton S, Ramnarain P, McHugh TD, Kibbler CC. Evaluation of a short, on-plate formic acid extraction method for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based identification of clinically relevant yeast isolates. J Clin Microbiol. 2014;52:1253–5.CrossRefPubMedCentralPubMed Gorton RL, Seaton S, Ramnarain P, McHugh TD, Kibbler CC. Evaluation of a short, on-plate formic acid extraction method for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based identification of clinically relevant yeast isolates. J Clin Microbiol. 2014;52:1253–5.CrossRefPubMedCentralPubMed
3.
Zurück zum Zitat Turhan O, Ozhak-Baysan B, Zaragoza O, Er H, Ongut G, Ogunc D, Colak D, Cuenca-Estrella M. Evaluation of MALDI-TOF-MS for the identification of yeast isolates causing bloodstream infection. Clin Lab. 2017;63:699–703.CrossRefPubMed Turhan O, Ozhak-Baysan B, Zaragoza O, Er H, Ongut G, Ogunc D, Colak D, Cuenca-Estrella M. Evaluation of MALDI-TOF-MS for the identification of yeast isolates causing bloodstream infection. Clin Lab. 2017;63:699–703.CrossRefPubMed
4.
Zurück zum Zitat Freel KC, Sarilar V, Neuvéglise C, Devillers H, Friedrich A, Schacherer J. Genome sequence of the yeast Cyberlindnera fabianii (Hansenula fabianii). Genome Announc. 2014;2:e00638–714.CrossRefPubMedCentralPubMed Freel KC, Sarilar V, Neuvéglise C, Devillers H, Friedrich A, Schacherer J. Genome sequence of the yeast Cyberlindnera fabianii (Hansenula fabianii). Genome Announc. 2014;2:e00638–714.CrossRefPubMedCentralPubMed
5.
6.
Zurück zum Zitat van Rijswijck IMH, Derks MF, Abee T, de Ridder D, de Ridder D, Smid EJde Ridder D, Smid EJ. Genome sequences of Cyberlindnera fabianii 65, Pichia kudriavzevii 129, and Saccharomyces cerevisiae 131 isolated from fermented masau fruits in Zimbabwe. Genome Announc. 2017;5:e00064–117.PubMedCentralPubMed van Rijswijck IMH, Derks MF, Abee T, de Ridder D, de Ridder D, Smid EJde Ridder D, Smid EJ. Genome sequences of Cyberlindnera fabianii 65, Pichia kudriavzevii 129, and Saccharomyces cerevisiae 131 isolated from fermented masau fruits in Zimbabwe. Genome Announc. 2017;5:e00064–117.PubMedCentralPubMed
7.
Zurück zum Zitat Valenza G, Valenza R, Brederlau J, Frosch M, Kurzai O. Identification of Candida fabianii as a cause of lethal septicaemia. Mycoses. 2006;49:331–4.CrossRefPubMed Valenza G, Valenza R, Brederlau J, Frosch M, Kurzai O. Identification of Candida fabianii as a cause of lethal septicaemia. Mycoses. 2006;49:331–4.CrossRefPubMed
8.
Zurück zum Zitat Bahafid W, Tahari Jouety N, Sayel H, Asri M, Laachari F, El Ghachtouli N. Soil bioaugmentation with Cyberlindnera fabianii diminish phytotoxic effects of chromium (VI) on Phaseolus vulgaris L. JMES. 2017;8:438–43. Bahafid W, Tahari Jouety N, Sayel H, Asri M, Laachari F, El Ghachtouli N. Soil bioaugmentation with Cyberlindnera fabianii diminish phytotoxic effects of chromium (VI) on Phaseolus vulgaris L. JMES. 2017;8:438–43.
10.
Zurück zum Zitat Svobodova L, Bednarova D, Ruzicka F, Chrenkova V, Dobias R, Mallatova N, Buchta V, Kocmanova I, Olisarova P, Stromerova N, Thongsri Y, Hamal P. High frequency of Candida fabianii among clinical isolates biochemically identified as Candida pelliculosa and Candida utilis. Mycoses. 2016;59:241–6.CrossRefPubMed Svobodova L, Bednarova D, Ruzicka F, Chrenkova V, Dobias R, Mallatova N, Buchta V, Kocmanova I, Olisarova P, Stromerova N, Thongsri Y, Hamal P. High frequency of Candida fabianii among clinical isolates biochemically identified as Candida pelliculosa and Candida utilis. Mycoses. 2016;59:241–6.CrossRefPubMed
11.
Zurück zum Zitat Suhr MJ, Hallen-Adams HE. The human gut mycobiome: pitfalls and potentials—a mycologist’s perspective. Mycologia. 2015;107:1057–73.CrossRefPubMed Suhr MJ, Hallen-Adams HE. The human gut mycobiome: pitfalls and potentials—a mycologist’s perspective. Mycologia. 2015;107:1057–73.CrossRefPubMed
12.
Zurück zum Zitat Bhally HS, Jain S, Shields C, Halsey N, Cristofalo E, Merz WG. Infection in a neonate caused by Pichia fabianii: importance of molecular identification. Med Mycol. 2006;44:185–7.CrossRefPubMed Bhally HS, Jain S, Shields C, Halsey N, Cristofalo E, Merz WG. Infection in a neonate caused by Pichia fabianii: importance of molecular identification. Med Mycol. 2006;44:185–7.CrossRefPubMed
13.
Zurück zum Zitat Grenouillet F, Millon L, Chamouine A, Thiriez G, Schulze O, Leroy J. Pichia fabianii fungemia in a neonate. Pediatr Infect Dis J. 2010;29:191.CrossRefPubMed Grenouillet F, Millon L, Chamouine A, Thiriez G, Schulze O, Leroy J. Pichia fabianii fungemia in a neonate. Pediatr Infect Dis J. 2010;29:191.CrossRefPubMed
14.
Zurück zum Zitat Wu Y, Wang J, Li W, Jia H, Che J, Lu J, Liu L, Cheng Y. Pichia fabianii blood infection in a premature infant in China: case report. BMC Res Notes. 2013;6:77.CrossRefPubMedCentralPubMed Wu Y, Wang J, Li W, Jia H, Che J, Lu J, Liu L, Cheng Y. Pichia fabianii blood infection in a premature infant in China: case report. BMC Res Notes. 2013;6:77.CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Mlinaric-Missoni EH, Hatvani S, Kocsubé S, Vagvölgyi C, Skaric I, Lukic-Grlic A. “Cyberlindnera fabianii” in the neonatal and paediatric intensive care unit: case reports. JMM Case Rep. 2015;2(no3):1–7.CrossRef Mlinaric-Missoni EH, Hatvani S, Kocsubé S, Vagvölgyi C, Skaric I, Lukic-Grlic A. “Cyberlindnera fabianii” in the neonatal and paediatric intensive care unit: case reports. JMM Case Rep. 2015;2(no3):1–7.CrossRef
16.
Zurück zum Zitat Lee JI, Yu S, Park JS, Joo E-J, Shin JH, Kwon M-J. Successful treatment of fungemia caused by Cyberlindnera fabianii with anidulafungin: a case report. Ann Clin Microbiol. 2015;18:94–7.CrossRef Lee JI, Yu S, Park JS, Joo E-J, Shin JH, Kwon M-J. Successful treatment of fungemia caused by Cyberlindnera fabianii with anidulafungin: a case report. Ann Clin Microbiol. 2015;18:94–7.CrossRef
17.
Zurück zum Zitat Buerth C, Tielker D, Ernst JF. Candida utilis and Cyberlindnera (Pichia) jadinii: yeast relatives with expanding applications. Appl Microbiol Biotechnol. 2016;100:6981–90.CrossRefPubMed Buerth C, Tielker D, Ernst JF. Candida utilis and Cyberlindnera (Pichia) jadinii: yeast relatives with expanding applications. Appl Microbiol Biotechnol. 2016;100:6981–90.CrossRefPubMed
18.
Zurück zum Zitat Tobudic S, Forstner C, Schranz H, Poeppl W, Vychytil A, Burgmann H. Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids. Mycoses. 2013;56:623–30.CrossRefPubMed Tobudic S, Forstner C, Schranz H, Poeppl W, Vychytil A, Burgmann H. Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids. Mycoses. 2013;56:623–30.CrossRefPubMed
19.
Zurück zum Zitat Municio C, Alvarez Y, Montero O, Hugo E, Rodríguez M, Domingo E, Alonso S, Fernández N, Crespo MS. The response of human macrophages to β-glucans depends on the inflammatory milieu. PLoS ONE. 2013;8:e62016.CrossRefPubMedCentralPubMed Municio C, Alvarez Y, Montero O, Hugo E, Rodríguez M, Domingo E, Alonso S, Fernández N, Crespo MS. The response of human macrophages to β-glucans depends on the inflammatory milieu. PLoS ONE. 2013;8:e62016.CrossRefPubMedCentralPubMed
Metadaten
Titel
Peritonitis in a neonate due to Cyberlindnera fabianii, an ascomycetic yeast
verfasst von
H. Hof
V. Amann
C. Tauber
A. Paulun
Publikationsdatum
20.08.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 6/2017
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1062-8

Weitere Artikel der Ausgabe 6/2017

Infection 6/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.